Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Jiayin Tian, Mingbo Zhang, Yingdai Zhao, Chaoshen Zhang & Xixiang Ying. (2023) Two new ester alkaloids from Portulaca oleracea L. and their bioactivities. Natural Product Research 37:23, pages 3915-3922.
Read now
Read now
Thomas Billiet, Isabelle Cleynen, Vera Ballet, Karolien Claes, Fred Princen, Sharat Singh, Marc Ferrante, Gert Van Assche, Ann Gils & Severine Vermeire. (2017) Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology 52:10, pages 1086-1092.
Read now
Read now
Amit Arya, Dharam Pal Pathak, Dipak K. Majumdar & Satish Manchanda. (2016) Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulations. Designed Monomers and Polymers 19:1, pages 34-46.
Read now
Read now
Rahil Dahlén, Maria K Magnusson, Antal Bajor, Anders Lasson, Kjell-Arne Ung, Hans Strid & Lena Öhman. (2015) Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy. Scandinavian Journal of Gastroenterology 50:9, pages 1118-1126.
Read now
Read now
Jon Florholmen. (2015) Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 43-52.
Read now
Read now
Bin Chen, Shifeng She, Detang Li, Zhihui Liu, Xiaojun Yang, Zhirong Zeng & Fengbin Liu. (2013) Role of miR-19a targeting TNF-α in mediating ulcerative colitis. Scandinavian Journal of Gastroenterology 48:7, pages 815-824.
Read now
Read now
Renathe Rismo, Trine Olsen, Guanglin Ciu, Eyvind J. Paulssen, Ingrid Christiansen, Jon Florholmen & Rasmus Goll. (2012) The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scandinavian Journal of Gastroenterology 47:10, pages 1200-1210.
Read now
Read now
Jon Florholmen & Walter Fries. (2011) Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology. Scandinavian Journal of Gastroenterology 46:12, pages 1407-1417.
Read now
Read now
Brett E Phillips & Nick Giannoukakis. (2010) Drug delivery technologies for autoimmune disease. Expert Opinion on Drug Delivery 7:11, pages 1279-1289.
Read now
Read now
Enzo Ierardi, Floriana Giorgio, Rosa Rosania, Mariangela Zotti, Simonetta Prencipe, Nicola Della Valle, Vincenzo De Francesco & Carmine Panella. (2010) Mucosal assessment of tumor necrosis factor alpha levels on paraffined samples: a comparison between immunohistochemistry and real time polymerase chain reaction. Scandinavian Journal of Gastroenterology 45:7-8, pages 1007-1008.
Read now
Read now
Kristian Bjøro. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:6, pages 644-645.
Read now
Read now
Articles from other publishers (37)
Shujuan Jiang, Yutong Jiang, Lingying Meng, Yanfeng Tuo & Guangqing Mu. (2024) β-lactoglobulin hydrolysates by L.plantarum AHQ-14 and L.bulgaricus BD0390 alleviate allergic responses to β-lactoglobulin in sensitized mice. Food Bioscience 58, pages 103770.
Crossref
Crossref
Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, Edoardo Savarino, Fabiana Zingone, Francesca Ometto, Marta Favero, Andrea Doria, Stephan R. Vavricka & Roberta Ramonda. (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nature Reviews Rheumatology 19:8, pages 503-518.
Crossref
Crossref
Sumel Ashique, Neeraj Mishra, Ashish Garg, Belay Zeleke Sibuh, Pankaj Taneja, Gopal Rai, Sinouvassane Djearamane, Ling Shing Wong, Noura Al-Dayan, Shatabhisha Roychoudhury, Kavindra Kumar Kesari, Petr Slama, Shubhadeep Roychoudhury & Piyush Kumar Gupta. (2023) Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis. Frontiers in Nutrition 10.
Crossref
Crossref
Hao Cheng, Dandan Zhang, Jing Wu, Juan Liu, Yuzhu Tan, Wuwen Feng & Cheng Peng. (2023) Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism. Frontiers in Immunology 14.
Crossref
Crossref
Guanglin Cui, Jon Florholmen & Rasmus Goll. (2022) Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?. Frontiers in Immunology 13.
Crossref
Crossref
Jianfang Zhang, Xiaomin Chen, Xinyi Mu, Mengwei Hu, Jiang Wang, Xiaojun Huang & Shaoping Nie. (2022)
Protective effects of flavonoids isolated from
Agrocybe aegirita
on dextran sodium sulfate‐induced colitis
. eFood 2:6, pages 288-295.
Crossref
Crossref
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll & Jon Florholmen. (2021) Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 66, pages 103329.
Crossref
Crossref
Xianshuo Cao, Guizhen Wang, Yong Yang, Yang Cao & Xianying Cao. (2021) Biomolecules induce the synthesis of hollow hierarchical mesoporous structured hydroxyapatite microflowers: application in macromolecule drug delivery. Journal of Materials Science 56:11, pages 7034-7049.
Crossref
Crossref
Lorenzo Bertani, Laura Baglietto, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Eleonora Albano, Linda Ceccarelli, Maria Gloria Mumolo, Carolina Pellegrini, Ersilia Lucenteforte, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Corrado Blandizzi & Francesco Costa. (2020) Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients. British Journal of Clinical Pharmacology 86:7, pages 1296-1305.
Crossref
Crossref
Biljana Bufan, Ivan Jančić & Zorica Stojić-Vukanić. (2020) Inhibitors of tumor necrosis factor-a and mechanisms of their action. Arhiv za farmaciju 70:3, pages 109-129.
Crossref
Crossref
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi & Francesco Costa. (2020) Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 65:4.
Crossref
Crossref
Angelo Armandi, Silvia Bonetto, Rinaldo Pellicano, Gian Paolo Caviglia, Marco Astegiano, Giorgio M. Saracco & Davide G. Ribaldone. (2019) Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message. Minerva Biotecnologica 31:3.
Crossref
Crossref
L. Allyson Checkley, Loretta Kristofek, Samantha Kile & William Bolgar. (2018) Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting. Digestive Diseases and Sciences 64:3, pages 855-862.
Crossref
Crossref
Takeo Yoshihara, Shinichiro Shinzaki, Shoichiro Kawai, Hironobu Fujii, Shuko Iwatani, Toshio Yamaguchi, Manabu Araki, Satoshi Hiyama, Takahiro Inoue, Yoshito Hayashi, Kenji Watabe, Hideki Iijima & Tetsuo Takehara. (2017) Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohnʼs Disease. Inflammatory Bowel Diseases 23:12, pages 2172-2179.
Crossref
Crossref
Caroline Meyer Olesen, Mehmet Coskun, Laurent Peyrin-Biroulet & Ole Haagen Nielsen. (2016) Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. Pharmacology & Therapeutics 159, pages 110-119.
Crossref
Crossref
Ulrike Billmeier, Walburga Dieterich, Markus F Neurath & Raja Atreya. (2016) Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World Journal of Gastroenterology 22:42, pages 9300.
Crossref
Crossref
Ihtzaz Ahmed Malik, Ina Stange, Gesa Martius, Silke Cameron, Margret Rave‐Fränk, Clemens Friedrich Hess, Volker Ellenrieder & Hendrik Andreas Wolff. (2015)
Role of
PECAM
‐1 in radiation‐induced liver inflammation
. Journal of Cellular and Molecular Medicine 19:10, pages 2441-2452.
Crossref
Crossref
Yanhong Shi, Zhenfeng Li, Wei Zheng, Xia Liu, Chenyi Sun, Jann-Birger Laugsand, Zhanju Liu & Guanglin Cui. (2015) Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update. Immunobiology 220:10, pages 1186-1196.
Crossref
Crossref
Satoshi Yamada, Takuya Yoshino, Minoru Matsuura, Naoki Minami, Takahiko Toyonaga, Yusuke Honzawa, Yoshihisa Tsuji & Hiroshi Nakase. (2014) Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience. BMC Gastroenterology 14:1.
Crossref
Crossref
Florian Martin, Alain Sewer, Marja Talikka, Yang Xiang, Julia Hoeng & Manuel C Peitsch. (2014) Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics 15:1.
Crossref
Crossref
Jung-Wook Kim, Hyo Jong Kim, Chang Kyun Lee, Jae-Jun Shim, Jae Young Jang, Suk Ho Dong, Byung-Ho Kim, Young Woon Chang & Sung-Gil Chi. (2014) Elevation of PRKCDBP, A Novel Transcriptional Target of TNF-α, and Its Downregulation by Infliximab in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 59:12, pages 2947-2957.
Crossref
Crossref
Marion T. Kasaian, Karen M. Page, Susan Fish, Agnes Brennan, Timothy A. Cook, Karen Moreira, Melvin Zhang, Michael Jesson, Kimberly Marquette, Rita Agostinelli, Julie Lee, Cara M. M. Williams, Lioudmila Tchistiakova & Paresh Thakker. (2014) Therapeutic activity of an interleukin‐4/interleukin‐13 dual antagonist on oxazolone‐induced colitis in mice. Immunology 143:3, pages 416-427.
Crossref
Crossref
Hiroshi Nakase, Takuya Yoshino & Minoru Matsuura. (2014) Role in Calcineurin Inhibitors for Inflammatory Bowel Disease in the Biologics Era. Inflammatory Bowel Diseases 20:11, pages 2151-2156.
Crossref
Crossref
Marta Sobczak, Adam Fabisiak, Natalia Murawska, Ewelina Wesołowska, Paulina Wierzbicka, Marcin Wlazłowski, Marta Wójcikowska, Hubert Zatorski, Marta Zwolińska & Jakub Fichna. (2014) Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacological Reports 66:5, pages 766-775.
Crossref
Crossref
Mustafa Hartavi, Selim Giray Nak, Barbaros Oral & Adem Deligönül. (2014) No association between the SOCS-1 −1478CA/del polymorphism and ulcerative colitis in Turkish subjects. Molecular Biology Reports 41:10, pages 6505-6508.
Crossref
Crossref
Aleksandra Piechota-Polanczyk & Jakub Fichna. (2014) Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn-Schmiedeberg's Archives of Pharmacology 387:7, pages 605-620.
Crossref
Crossref
Elzbieta Kaczmarek, Tomasz Banasiewicz, Agnieszka Seraszek-Jaros, Piotr Krokowicz, Marcin Grochowalski, Przemysław Majewski, Jakub Zurawski, Jacek Paszkowski & Michał Drews. (2014) Digital image analysis of inflammation markers in colorectal mucosa by using a spatial visualization method. Pathology - Research and Practice 210:3, pages 147-154.
Crossref
Crossref
R. Dahlén, H. Strid, A. Lundgren, S. Isaksson, S. Raghavan, M. K. Magnusson, M. Simrén, H. Sjövall & L. Öhman. (2013)
Infliximab Inhibits Activation and Effector Functions of Peripheral Blood
T
Cells
in vitro
from Patients with Clinically Active Ulcerative Colitis
. Scandinavian Journal of Immunology 78:3, pages 275-284.
Crossref
Crossref
Yuan Guo, Nonghua Lu & Aiping Bai. (2013) Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
F. Scaldaferri, V. Petito, L. Lopetuso, G. Bruno, V. Gerardi, G. Ianiro, A. Sgambato, A. Gasbarrini & G. Cammarota. (2013) Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives. Mediators of Inflammation 2013, pages 1-9.
Crossref
Crossref
Bertalan Mesko, Gabor Zahuczky & Laszlo Nagy. (2012) The triad of success in personalised medicine: pharmacogenomics, biotechnology and regulatory issues from a Central European perspective. New Biotechnology 29:6, pages 741-750.
Crossref
Crossref
Federico Moriconi, Ihtzaz Ahmed Malik, Ahmad Amanzada, Martina Blaschke, Dirk Raddatz, Sajjad Khan & Giuliano Ramadori. (2012) The anti-TNF-α antibody infliximab indirectly regulates PECAM-1 gene expression in two models of in vitro blood cell activation. Laboratory Investigation 92:2, pages 166-177.
Crossref
Crossref
Gary Toedter, Katherine Li, Colleen Marano, Keying Ma, Sarah Sague, Chris C Huang, Xiao-Yu Song, Paul Rutgeerts & Frédéric Baribaud. (2011) Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis. American Journal of Gastroenterology 106:7, pages 1272-1280.
Crossref
Crossref
J. Florholmen, G. Øverland, T. Olsen, R. Rismo, G. Cui, I. Christiansen, E. J. Paulssen & R. Goll. (2011) Short-and Long-Term Clinical Outcomes of Infliximab in Fulminant Ulcerative Colitis. Ulcers 2011, pages 1-7.
Crossref
Crossref
Rivkah Gonsky, Richard L. Deem, Carol J. Landers, Carrie A. Derkowski, Dror Berel, Dermot P.B. McGovern & Stephan R. Targan. (2011) Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens. Inflammatory Bowel Diseases 17:1, pages 171-178.
Crossref
Crossref
Thomas W. Lee & Richard N. Fedorak. (2010) Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology. Gastroenterology Clinics of North America 39:3, pages 543-557.
Crossref
Crossref
Trine Olsen & Jon Florholmen. (2010) Cytokine mRNA expression in steroid-naïve patients with ulcerative colitis. Inflammatory Bowel Diseases 16:5, pages 734.
Crossref
Crossref